The FDA has issued a Complete Response Letter to Telix Pharmaceuticals regarding the NDA for TLX101-CDx for the imaging of gliomas.

UC Davis Health's first-of-its-kind total body scanner EXPLORER is being given yet another new assignment—assessing how ...

The following is a summary of "What is the accuracy, sensitivity and specificity of the radiological peritoneal cancer index ...

In an article published in Genomic Psychiatry, researchers from Fudan University and Shanghai University of Traditional ...

The center is named in honor of a generous donation from the Mead family, whose commitment to supporting local health care is ...

Company plans to file NDA in the third quarter of this yearBEDFORD, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading ...

Lantheus Holdings said an imaging agent designed to identify markers of Alzheimer's disease showed promise in two clinical trials.

Listening to our favorite music activates the same parts of the brain as food and sex, reveals new research. The study showed ...

XingImaging, a MITRO company, a pioneer in advanced research imaging, radiopharmaceutical services, and medical imaging ...

Construction already underway will create additional triage space and six new vertical treatment areas for less serious ...

Chinese researchers have made significant progress in developing positron emission tomography (PET) tracers that can ...